BB

Bhausaheb Balnath Ghoderao

Active Director Designated Partner DIN 11116320
DIN 11116320 First appointment May 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhausaheb Balnath Ghoderao

Data last updated:

Bhausaheb Balnath Ghoderao is a Designated Partner at Rgd Pathology Lab Llp (since 2025).

DIN 11116320
Primary Designation Designated Partner
First Appointment 20 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner20 May 20252025Active

Board colleagues of Bhausaheb Balnath Ghoderao

NameDINCompanyDesignation
Pooja Ambadas Ranbhare11116322Rgd Pathology Lab LlpDesignated Partner
Sachin Bapu Dhamdhare11116321Rgd Pathology Lab LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Rgd Pathology Lab Llp
Premium access

Shareholding and investment profile for Bhausaheb Balnath Ghoderao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhausaheb Balnath Ghoderao

Bhausaheb Balnath Ghoderao currently holds 1 directorship: Rgd Pathology Lab Llp (Designated Partner, since 20 May 2025).

Bhausaheb Balnath Ghoderao was first appointed on 20 May 2025 as Designated Partner at Rgd Pathology Lab Llp.

The current boards of Bhausaheb Balnath Ghoderao's companies include Pooja Ambadas Ranbhare (Rgd Pathology Lab Llp), Sachin Bapu Dhamdhare (Rgd Pathology Lab Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available